Home

Pfizer (PFE)

26.43
+0.58 (2.24%)
NYSE · Last Trade: Dec 15th, 6:04 PM EST
QuoteNewsPress ReleasesChartHistoricalFAQAboutCompetitors
These S&P500 stocks are the most active in today's sessionchartmill.com
Explore the S&P500 index on Monday and find out which stocks are the most active in today's session. Stay updated with the stocks that are capturing market interest.
Via Chartmill · December 15, 2025
Pfizer Faces Another Quiet Year As Patent Losses Cloud 2026 Outlook: Analystbenzinga.com
Pfizer to provide full-year 2026 financial guidance on Tuesday. BofA analyst expects flat growth, reiterates Neutral rating.
Via Benzinga · December 15, 2025
Will Dogecoin Reach $1 By the End of the Year?fool.com
Dogecoin's price would need to rise more than seven-fold before the calendar turns to 2026.
Via The Motley Fool · December 15, 2025
Should You Forget Teva Pharmaceutical and Buy These Unstoppable Stocks Instead?fool.com
Teva Pharmaceutical is a leader in generic drugs, but these struggling makers of branded drugs may be a better choice.
Via The Motley Fool · December 14, 2025
Forget Teladoc and Buy This Healthcare Stock Insteadfool.com
It's time for investors to give up on the telemedicine leader.
Via The Motley Fool · December 13, 2025
Pfizer Is Still Struggling to Replace Its COVID Revenue. Here's What We Could See From the Pharmaceutical Giant in 2026.fool.com
Keep your expectations in check.
Via The Motley Fool · December 12, 2025
The Best Turnaround Stock to Invest $1,000 in Right Nowfool.com
Pfizer and Bristol Myers Squibb are deeply out-of-favor drugmakers, but one could be the better turnaround candidate if you think long term.
Via The Motley Fool · December 12, 2025
The Great Divergence: Investors Retreat from High-Flying Tech as Market Seeks New Equilibrium
The financial markets are witnessing a significant "Great Divergence" as investor sentiment pivots sharply away from the high-flying technology stocks that have dominated portfolios for years. As of December 11, 2025, a palpable shift is underway, with capital flowing out of the tech sector and into more traditional, value-oriented industries.
Via MarketMinute · December 11, 2025
Great Rotation: Tech Exodus Fuels Dow's Record Run While Nasdaq Struggles
As of December 12, 2025, the financial markets are witnessing a significant "Great Rotation," a pronounced shift of capital from high-growth technology and Artificial Intelligence (AI) stocks to more traditional value sectors and defensive equities. This ongoing recalibration reflects evolving macroeconomic conditions, a reassessment of risk appetite, and a growing
Via MarketMinute · December 12, 2025
Value Stocks Stage a Comeback Bid Amidst Persistent Growth Dominance
The financial markets in late 2025 present a complex narrative, a tug-of-war between the long-reigning titans of growth and a resurgent, yet often overshadowed, cohort of value stocks. While the year-to-date performance figures as of December 11, 2025, still crown growth equities as the overall victors, a closer look reveals
Via MarketMinute · December 11, 2025
Moderna And Super Micro Top S&P 500 Short Interest List — Are They Ripe For A Squeeze?stocktwits.com
Investors remain divided on Moderna and Super Micro as heavy short interest reflects skepticism, yet recent catalysts suggest both names could still deliver unpredictable, sentiment-driven swings.
Via Stocktwits · December 11, 2025
Warning: This Skyrocketing Stock Has a Hidden Riskfool.com
Following a significant price increase due to the company's industry-leading weight loss drugs, investors must now consider what comes next.
Via The Motley Fool · December 10, 2025
Pfizer's Tukysa Combo Shows Strong PFS Benefit In Metastatic Breast Cancerbenzinga.com
Pfizer reports Phase 3 results showing Tukysa with trastuzumab and pertuzumab prolonged progression-free survival by 8.6 months in HER2+ metastatic breast cancer.
Via Benzinga · December 10, 2025
Markets Brace for Anticipated Fed Rate Cut Amidst Shifting Economic Landscape
As December 2025 draws to a close, financial markets are holding their breath in anticipation of a pivotal Federal Reserve interest rate decision. Investopedia's analysis reveals a pervasive market sentiment leaning heavily towards a quarter-percentage-point reduction in the federal funds rate, a move that would mark the third consecutive cut
Via MarketMinute · December 10, 2025
Down 50%, Should You Buy the Dip on Pfizer?fool.com
Pfizer's stock has fallen by more than 50% from its 2021 highs and faces some headwinds, but remains worth a deep dive for long-term investors.
Via The Motley Fool · December 9, 2025
Looking for the most active stocks in the S&P500 index on Tuesday?chartmill.com
Stay informed about the most active S&P500 stocks in today's session as we take a closer look at what's happening on the US markets on Tuesday. Discover the stocks that are generating the highest trading volume and driving market activity.
Via Chartmill · December 9, 2025
PFE Stock Gains In Premarket – What Is The Deal With Shanghai Fosun Pharma’s Unit About?stocktwits.com
Pfizer signed an exclusive global collaboration and licensing agreement with YaoPharma to develop YP05002, a small-molecule GLP-1 receptor agonist for chronic weight management.
Via Stocktwits · December 9, 2025
U.S. Households Brace for Financial Headwinds Despite Steady Inflation, New York Fed Reports
New York, NY – December 8, 2025 – A recent report from the Federal Reserve Bank of New York (New York Fed) reveals a concerning trend: U.S. households are growing increasingly pessimistic about their financial situations, even as inflation expectations remain largely stable. Released today, the November 2025 Survey of Consumer
Via MarketMinute · December 8, 2025
How Do Investors Really Feel About Pfizer Inc?benzinga.com
Via Benzinga · December 8, 2025
Nasdaq, S&P 500 Futures Rise Ahead Of Fed Decision This Week: Why NFLX, CFLT, BA, LLY, IMMX Are On Traders' Radarstocktwits.com
Market-based odds now show an 87% chance of a rate cut.
Via Stocktwits · December 8, 2025
3 Cash-Producing Stocks with Exciting Potential
Free cash flow is one of the most reliable indicators of financial durability. These businesses not only generate cash but reinvest intelligently to sustain momentum.
Via StockStory · December 7, 2025
Do These 3 Healthcare Stocks Need a Checkup?fool.com
These three drugmakers are all well off their recent highs. Is this a sign of opportunity or risk?
Via The Motley Fool · December 5, 2025
Why Is Moderna (MRNA) Stock Rocketing Higher Today
Shares of biotechnology company Moderna (NASDAQ:MRNA) jumped 6.4% in the afternoon session after a major long-term study from France indicated that its COVID-19 vaccine was safe and effective. 
Via StockStory · December 5, 2025
Curious about the most active S&P500 stocks in today's session?chartmill.com
Explore the S&P500 index on Friday and find out which stocks are the most active in today's session. Stay updated with the stocks that are capturing market interest.
Via Chartmill · December 5, 2025
Is This Pharmaceutical Giant a Buy After a Major Acquisition?fool.com
The rebound is well underway.
Via The Motley Fool · December 5, 2025